Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions

Applied and Environmental Microbiology

Volumn 66, Issue 4, 2000, Pages 1572-1579

  Barth, S ^a,c   Huhn, M ^a   Matthey, B ^a   Klimka, A ^a   Galinski, E A ^b   Engert, A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; ELECTROLYTE; HYDROXYECTOINE; IMMUNOTOXIN; INORGANIC SALT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; OSMOTIC STRESS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; RECOMBINANT DNA TECHNOLOGY; TECHNIQUE;

ANIMALS; ANTIGENS, CD30; BETAINE; COS CELLS; CRYOPRESERVATION; CULTURE MEDIA; ESCHERICHIA COLI; HUMANS; HYBRIDOMAS; IMMUNOTOXINS; OSMOTIC PRESSURE; PERIPLASM; PLASMIDS; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; TOXICITY TESTS; TUMOR CELLS, CULTURED;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; PROKARYOTA;

EID: 0034082797     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.66.4.1572-1579.2000     Document Type: Article

References (39)

1. Altamiro, M. M., C. Garcia, L. D. Possani, and A. R. Fersht. 1999. Oxidative refolding chromatography: folding of the scorpion toxin Cn5. Nat. Biotechnol. 17:187-191.
2. Baneyx, F., and G. Georgiou. 1992. Degradation of secreted proteins in Escherichia coli. Ann. N. Y. Acad. Sci. 665:301-308.
3. Bargou, R. C., M. Y. Mapara, C. Zugck, P. T. Daniel, M. Pawlita, H. Dohner, and B. Dorken. 1993. Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice. J. Exp. Med. 177:1257-1268.
4. + Hodgkin-derived cell lines. Int. J. Mol. Med. 1:249-256.
5. Barth, S., B. Matthey, M. Huhn, V. Diehl, and A. Engert. 1999 CD30L-ETA′: a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma. Cytokines Cell. Mol. Ther. 5:69-78.
6. Benhar, I., and I. Pastan. 1994. Cloning, expression and characterization of the Fv fragments of the anti-carhohydrate mAbs B1 and B5 as single-chain immunotoxins. Protein Eng. 7:1509-1515.
7. Blackwell, J. R., and R. Horgan. 1991. A novel strategy for production of a highly expressed recombinant protein in an active form. FEBS Lett. 295:10-12.
8. Brown, A. D. 1976. Microbial water stress. Bacteriol. Rev. 40:803-846.
9. Buchner, J., I. Pastan, and U. Brinkmann. 1992. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205: 263-270.
10. Csonka, L., and W. Epstein. 1996. Osmoregulation, p. 1210-1223. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C.
11. Dower, W. J., J. F. Miller, and C. W. Ragsdale. 1988. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res 16:6127-6145.
12. Durkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992 Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68: 421-427.
13. Engert, A., G. Martin, P. Amlot, J. Wijdenes, V. Diehl, and P. Thorpe. 1991. Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice. Int. J. Cancer 49:450-456.
14. Essen, L., and A. Skerra. 1993. Single-step purification of a bacterially expressed antibody Fv fragment by immobilized metal affinity chromatography in the presence of betaine. J. Chromatogr. A 657:55-61.
15. FitzGerald, D., I. Pastan, and J. Robertus. 1998. Clinical applications of immunotoxins. Introduction. Curr. Top. Microbiol. Immunol. 234:1-11.
16. Galinski, E. 1995. Osmoadaptation in bacteria. Adv. Microb. Physiol. 37: 272-328.
17. Galloway, D. R., R. C. Hedstrom, and O. R. Pavlovskis. 1984. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa. Infect. Immun. 44:262-267.
18. Göller, K., and E. A. Galinski. 1999. Protection of a model enzyme (lactate dehydrogenase) against heat, urea and freeze-thaw treatment by compatible solute additives. J. Mol. Catal. B Enzymatic 7:37-45.
19. Hengge-Aronis, R. 1996. Back to log phase: sigma S as a global regulator in the osmotic control of gene expression in Escherichia coli. Mol. Microbiol. 21:887-893.
20. Hochuli, E., H. Dobeli, and A. Schacher. 1987. New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues. J. Chromatogr. 411:177-184.
21. Holliger, P., and G. Winter. 1997. Diabodies: small bispecific antibody fragments. Cancer Immunol. Immunother. 45:128-130.
22. Hoogenboom, H. R., J. D. Marks, A. D. Griffiths, and G. Winter. 1992. Building antibodies from their genes. Immunol. Rev. 130:41-68.
23. Horn-Lohrens, O., M. Tiemann, H. Lange, J. Kobarg, M. Hafner, H. Hansen, W. Sterry, R. Parwaresch, and H. Lemke. 1995. Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4). Int. J. Cancer 60:539-544.
24. Jost, L. M., J. M. Kirkwood, and T. L. Whiteside. 1992. Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J. Immunol. Methods 147:153-165.
25. Kapp, U., J. Wolf, C. von Kalle, S. Tawadros, A. Rottgen, A. Engert, C. Fonatsch, H. Stein, and V. Diehl. 1992. Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice. Ann. Oncol. 3(Suppl. 4):21-23.
26. Klimka, A., S. Barth, S. Drillich, W. Wels, J. van Snick, J. C. Renauld, H. Tesch, H. Bohlen, V. Diehl, and A. Engert. 1996. A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rh1L-9-ETA′) shows specific cytotoxicity against IL-9-receptor-expressing cell lines. Cytokines Mol. Ther. 2:139-146.
27. Klimka, A., S. Barth, B. Matthey, R. C. Roovers, H. Lemke, H. Hansen, J. W. Arends, V. Diehl, H. R. Hoogenboom, and A. Engert. 1999. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA′) is a potent immunotoxin against a Hodgkin-derived cell line. Br. J. Cancer 80:1214-1222.
28. Knapp, S., R. Ladenstein, and E. A. Galinski. 1999. Thermal stabilisation of bovine ribonuclease A by the naturally occurring osmolytes beta-hydroxyectoine and betaine. Extremophiles 3:191-198.
29. Kreitman, R., and I. Pastan. 1994. Recombinant toxins. Adv. Pharmacol. 28:193-219.
30. Lippert, K., and E. A. Galinski. 1992. Enzyme stabilization by ectoine-type compatible solutes: protection against heating, freezing and drying. Appl. Microbiol. Biotechnol. 37:61-65.
31. Matthey, B., A. Engert, A. Klimka, V. Diehl, and S. Barth. 1999. A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins. Gene 229:145-153.
32. McCafferty, J., K. J. Fitzgerald, J. Earnshaw, D. J. Chiswell, J. Link, R. Smith, and J. Kenten. 1994. Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display. Appl. Biochem. Biotechnol. 47:157-171.
33. Pastan, I., and D. FitzGerald. 1991. Recombinant toxins for cancer treatment. Science 254:1173-1177.
34. Phillips, G., and T. Silhavy. 1990. Heat-shock proteins DnaK and GroEL facilitate export of LacZ hybrid proteins in E. coli. Nature 344:882-884.
35. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
36. Studier, F. W., and B. A. Moffalt. 1986. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189:113-130.
37. Talmadge, K., and W. Gilbert. 1982. Cellular location affects protein stability in Escherichia coli. Proc. Natl. Acad. Sci. USA 79:1830-1833.
38. Van Wuytswinkel, O., G. Savino, and J. Briat. 1995. Purification and characterization of recombinant pea-seed ferritins expressed in Escherichia coli: influence of N-terminus deletions on protein solubility and core formation in vitro. Biochem. J. 305:253-261.
39. Wels, W., I. Harwerth, M. Mueller, B. Groner, and N. Hynes. 1992. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res. 52:6310-6317.